{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:52:19Z","timestamp":1791661939656,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-070"],"award-info":[{"award-number":["2021-I2M-1-070"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biopha.2022.113657","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T09:34:07Z","timestamp":1662543247000},"page":"113657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Established new compound IMB16-4 self-emulsifying drug delivery systems for increasing oral bioavailability and enhancing anti-hepatic fibrosis\u00a0effect"],"prefix":"10.1016","volume":"154","author":[{"given":"Xia","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113657_bib1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4254\/wjh.v14.i2.354","article-title":"Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: can we stratify at-risk populations?","volume":"14","author":"Fassio","year":"2022","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.biopha.2022.113657_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113657_bib3","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.3748\/wjg.v26.i41.6304","article-title":"Efficacy and safety of anti-hepatic fibrosis drugs","volume":"26","author":"Damiris","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.113657_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7629724","article-title":"Clinical advancements in the targeted therapies against liver fibrosis","volume":"2016","author":"Bansal","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2022.113657_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.118.256156","article-title":"Targeted drug delivery to hepatic stellate cells for the treatment of liver fibrosis","volume":"370","author":"Chen","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2022.113657_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00204-015-1580-z","article-title":"A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives","volume":"90","author":"Domitrovic","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2022.113657_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2012.05.007","article-title":"Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4\/NOX1 inhibitor in vivo","volume":"53","author":"Jiang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.113657_bib8","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the treatment of liver fibrosis","volume":"12","author":"Poilil Surendran","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2022.113657_bib9","article-title":"Dually active polycation\/miRNA nanoparticles for the treatment of fibrosis in alcohol-associated liver disease","volume":"14","author":"Zhang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2022.113657_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12565-017-0395-9","article-title":"The stellate cell system (vitamin A-storing cell system)","volume":"92","author":"Senoo","year":"2017","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.biopha.2022.113657_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6175091","article-title":"Isorhamnetin inhibits liver fibrosis by reducing autophagy and inhibiting extracellular matrix formation via the TGF-beta1\/Smad3 and TGF-beta1\/p38 MAPK pathways","volume":"2019","author":"Liu","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2022.113657_bib12","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1111\/jcmm.15175","article-title":"TGF-beta\/Smad and JAK\/STAT pathways are involved in the anti-fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis","volume":"24","author":"Xu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2022.113657_bib13","first-page":"304","article-title":"Causes and methods of assessment, a review","volume":"53","author":"Toosi","year":"2015","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.biopha.2022.113657_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.26698","article-title":"Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113657_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ph15010085","article-title":"New IMB16-4 nanoparticles improved oral bioavailability and enhanced anti-hepatic fibrosis on rats","volume":"15","author":"Niu","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2022.113657_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26061545","article-title":"Novel IMB16-4 compound loaded into silica nanoparticles exhibits enhanced oral bioavailability and increased anti-liver fibrosis in vitro","volume":"26","author":"Niu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.113657_bib17","unstructured":"R. Kadian, A. Nanda, A comprehensive insight on self emulsifying drug delivery systems, Recent Adv Drug Deliv Formul, (2021)."},{"key":"10.1016\/j.biopha.2022.113657_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2021038490","article-title":"Recent progress in self-emulsifying drug delivery systems: a systematic patent review (2011-2020)","volume":"39","author":"Ruiz","year":"2022","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.biopha.2022.113657_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v33.i1.20","article-title":"Current trends in self-emulsifying drug delivery systems (SEDDSs) to enhance the bioavailability of poorly water-soluble drugs","volume":"33","author":"Karwal","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.biopha.2022.113657_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i5.10","article-title":"Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications","volume":"26","author":"Singh","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"10.1016\/j.biopha.2022.113657_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejpb.2017.03.012","article-title":"Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin","volume":"115","author":"Kollner","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2022.113657_bib22","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/jphp.12286","article-title":"In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems","volume":"66","author":"Heshmati","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113657_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bmcl.2014.11.071","article-title":"A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS)","volume":"25","author":"Beaulieu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.113657_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/0250-474X.164773","article-title":"Effective surfactants blend concentration determination for o\/w emulsion stabilization by two nonionic surfactants by simple linear regression","volume":"77","author":"Hassan","year":"2015","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2022.113657_bib25","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2022.113657_bib26","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1023\/A:1016085108889","article-title":"Gastrointestinal uptake of biodegradable microparticles: effect of particle size","volume":"13","author":"Desai","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2022.113657_bib27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1289\/ehp.8006","article-title":"Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells","volume":"113","author":"Geiser","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.biopha.2022.113657_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2022.113657_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(20)31930-2","article-title":"Pentadecapeptide Bpc 157 therapy in bile duct ligated (Bdl) Rats. In rats with cirrhosis and portal hypertension, Bpc 157 may be useful also in the conditions of the increased intracranial pressure and vessels obstruction","volume":"158","author":"Sever","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.113657_bib30","first-page":"830a","article-title":"Pinealectomy or prolonged light exposure exacerbates biliary proliferation and senescence and liver fibrosis in bile duct ligated (BDL) rats via decreased biliary melatonin synthesis","volume":"68","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113657_bib31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113657_bib32","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1097\/CM9.0000000000000835","article-title":"Regression of liver fibrosis: evidence and challenges","volume":"133","author":"Sun","year":"2020","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.biopha.2022.113657_bib33","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1582-4934.2008.00262.x","article-title":"Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice","volume":"12","author":"Hamzavi","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2022.113657_bib34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/jhep.2003.50196","article-title":"Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis","volume":"37","author":"Ueberham","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113657_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-5793(01)02656-4","volume":"502","author":"Dooley","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2022.113657_bib36","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/ars.2017.7064","article-title":"Role of platelet-derived transforming growth factor-beta1 and reactive oxygen species in radiation-induced organ fibrosis","volume":"27","author":"Ahamed","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2022.113657_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:43:10Z","timestamp":1791661390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222010460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":37,"alternative-id":["S0753332222010460"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113657","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Established new compound IMB16-4 self-emulsifying drug delivery systems for increasing oral bioavailability and enhancing anti-hepatic fibrosis\u00a0effect","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113657"}}